Korean J Intern Med.  2014 Nov;29(6):703-712. 10.3904/kjim.2014.29.6.703.

The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry

Affiliations
  • 1The Heart Center, Chonnam National University Hospital, Gwangju, Korea. myungho@chollian.net
  • 2Cardiovascular Center, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
  • 3Cardiovascular Center, Chungbuk National University Hospital, Cheongju, Korea.
  • 4Cardiovascular Center, Yeungnam University Medical Center, Daegu, Korea.

Abstract

The Korea Acute Myocardial Infarction Registry (KAMIR) was the first nationwide registry data collection designed to track outcomes of patients with acute myocardial infarction (AMI). These studies reflect the current therapeutic approaches and management for AMI in Korea. The results of KAMIR could help clinicians to predict the prognosis of their patients and identify better diagnostic and treatment tools to improve the quality of care. The KAMIR score was proposed to be a predictor of the prognosis of AMI patients. Triple antiplatelet therapy, consisting of aspirin, clopidogrel and cilostazol, was effective at preventing major adverse clinical outcomes. Drug-eluting stents were effective and safe in AMI patients with no increased risk of stent thrombosis. Statin therapy was effective in Korean AMI patients, including those with very low levels of low density cholesterol. The present review summarizes the 10-year scientific achievements of KAMIR from admission to outpatient care during long-term clinical follow-up.

Keyword

Acute myocardial infarction; Prognosis; Therapeutics

MeSH Terms

Humans
*Myocardial Infarction/diagnosis/mortality/therapy
Predictive Value of Tests
Quality Improvement
Quality of Health Care
*Registries
Republic of Korea/epidemiology
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr